Here, using a cellular thermal shift assay (CETSA), we demonstrate that compounds 1 and 2 engage with tNOX and inhibit SIRT1 to induce apoptosis against both p53-wild-type and p53-deficient HCC cell lines. This evidence concerns the gene TP53 and hepatocellular carcinoma.